Markets:

Overview

News

Currencies

International

Treasuries

Cytokinetics, Incorporated - Common Stock (NQ:CYTK)

69.15 +1.00 (+1.47%)

Streaming Delayed Price Updated: 10:18 AM EST, Nov 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cytokinetics, Incorporated - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

30 Stocks Moving In Monday's Mid-Day Session ↗

July 19, 2021

Gainers Cytokinetics, Incorporated (NASDAQ: CYTK) jumped 56.4% to $30.07 after the company disclosed topline results from Cohorts 1 and 2 of REDWOOD-HCM. Aehr Test Systems (...

Via Benzinga

CYTK Stock Flies High on Exciting Drug Trial Results ↗

July 19, 2021

CYTK stock is being boosted by bullish biopharma buyers today. The company is reporting with optimism regarding its newest HCM treatment.

Via InvestorPlace

How Strong Cytokinetics Test Results Could Undermine Bristol Myers' $13.1 Billion Buyout ↗

July 19, 2021

Cytokinetics said Monday its treatment improved blood flow for patients with a genetic heart disease, and the biotech stock sprinted.

Via Investor's Business Daily

Mid-Morning Market Update: Markets Open Lower; AutoNation Profit Beats Estimates ↗

July 19, 2021

Following the market opening Monday, the Dow traded down 2.31% to 33,885.81 while the NASDAQ fell 1.67% to 14,186.04. The S&P also fell, dropping 1.94% to 4,243.38. The U.S....

Via Benzinga

Topics Stocks

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

Stocks That Hit 52-Week Highs On Monday ↗

July 19, 2021

On Monday morning, 20 companies achieved new highs for the year. Areas of Significance: The largest company by market cap to break to a new 52-week high was PepsiCo...

Via Benzinga

Cytokinetics Shares Gain On Positive Data From Heart Disease Candidate ↗

July 19, 2021

Cytokinetics Incorporated (NASDAQ: CYTK) has announced positive topline results from Cohorts 1 and 2 of REDWOOD-HCM Phase 2 trial of CK-3773274 (CK-274) in...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 19, 2021

Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock moved upwards by 67.6% to $14.28 during Monday's pre-market session. The company's market cap stands at $684.2...

Via Benzinga

Cytokinetics Post-Hoc Data Suggests Omecamtiv Mecarbil Works Better In High-Risk Patients For Heart Failure ↗

May 17, 2021

Cytokinetics Incorporated (NASDAQ: CYTK) announced secondary data analysis from the GALACTIC-HF trial evaluating omecamtiv mecarbil in patients with heart...

Via Benzinga

Cytokinetics Inc (CYTK) Q1 2021 Earnings Call Transcript ↗

May 07, 2021

CYTK earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Astellas Walks Away From $450M Research & Discovery Partnership With Cytokinetics ↗

May 03, 2021

Cytokinetics Inc (NASDAQ: CYTK) revealed in an SEC filing that Astellas Pharma Inc (OTCMKTS: ALPMY) is walking away from a pact to research and...

Via Benzinga

Topics Regulatory Compliance

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.